Eye Drugs Roughly Equal at Preserving Vision: Study

May 1, 2012
The results of a closely watched study funded by the U.S. government show that the drugs Avastin and Lucentis are roughly equal at preserving vision in elderly people with a common eye disease, a finding that could potentially save Medicare and other insurers millions of dollars a year because Avastin is far less expensive than Lucentis.
The Wall Street Journal